[
  {
    "ts": null,
    "headline": "Closing Bell Movers: Amazon soars to all-time highs on earnings",
    "summary": "In the opening hour of the evening session, U.S. equity futures are notably higher, with S&P 500 up 0.5% and Nasdaq 100 contracts up 1.0%. In commodities, WTI Crude Oil is little changed just above $60 per barrel while precious metals are stronger for the 3rd day in a row – Gold is above $4,040 and Silver is approaching $49 per ounce. A strong slate of quarterly Tech results are helping stock futures restore positive sentiment in the segment that was wounded on Thursday by more dubious results o",
    "url": "https://finnhub.io/api/news?id=3a1414e7215f21517b4d9eda8279f4f818c5451572e22aedcf307017745338b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761953738,
      "headline": "Closing Bell Movers: Amazon soars to all-time highs on earnings",
      "id": 137286030,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "In the opening hour of the evening session, U.S. equity futures are notably higher, with S&P 500 up 0.5% and Nasdaq 100 contracts up 1.0%. In commodities, WTI Crude Oil is little changed just above $60 per barrel while precious metals are stronger for the 3rd day in a row – Gold is above $4,040 and Silver is approaching $49 per ounce. A strong slate of quarterly Tech results are helping stock futures restore positive sentiment in the segment that was wounded on Thursday by more dubious results o",
      "url": "https://finnhub.io/api/news?id=3a1414e7215f21517b4d9eda8279f4f818c5451572e22aedcf307017745338b6"
    }
  },
  {
    "ts": null,
    "headline": "Why Stryker (SYK) Shares Are Trading Lower Today",
    "summary": "Shares of medical technology company Stryker (NYSE:SYK) fell 2.9% in the afternoon session after it reported underwhelming earnings. Stryker's revenue grew 10.2% year on year to $6.06 billion, meeting expectations, while its adjusted earnings per share of $3.19 topped consensus estimates. Despite these positive headline numbers and a slight lift in its full-year earnings guidance, investors appeared to focus on a decline in profitability. The company's operating margin contracted to 18.7% from 1",
    "url": "https://finnhub.io/api/news?id=e4e8058f5f2f2b774ef9c9ae08b5aeffeb356866fc73d3706fd009bdb53ac5a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761938476,
      "headline": "Why Stryker (SYK) Shares Are Trading Lower Today",
      "id": 137286031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Shares of medical technology company Stryker (NYSE:SYK) fell 2.9% in the afternoon session after it reported underwhelming earnings. Stryker's revenue grew 10.2% year on year to $6.06 billion, meeting expectations, while its adjusted earnings per share of $3.19 topped consensus estimates. Despite these positive headline numbers and a slight lift in its full-year earnings guidance, investors appeared to focus on a decline in profitability. The company's operating margin contracted to 18.7% from 1",
      "url": "https://finnhub.io/api/news?id=e4e8058f5f2f2b774ef9c9ae08b5aeffeb356866fc73d3706fd009bdb53ac5a7"
    }
  },
  {
    "ts": null,
    "headline": "Compared to Estimates, Stryker (SYK) Q3 Earnings: A Look at Key Metrics",
    "summary": "The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=ecb989f276ff98bb9a0231311cbc6de70714f2f4cbf62ce7714887c1ee5a7135",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761933601,
      "headline": "Compared to Estimates, Stryker (SYK) Q3 Earnings: A Look at Key Metrics",
      "id": 137286032,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
      "url": "https://finnhub.io/api/news?id=ecb989f276ff98bb9a0231311cbc6de70714f2f4cbf62ce7714887c1ee5a7135"
    }
  },
  {
    "ts": null,
    "headline": "SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up",
    "summary": "Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=12f99e6297268fea11cc7f545dfb00552810c82ea0661e073dcb0c5f80dda3e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761920280,
      "headline": "SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up",
      "id": 137279198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=12f99e6297268fea11cc7f545dfb00552810c82ea0661e073dcb0c5f80dda3e2"
    }
  },
  {
    "ts": null,
    "headline": "SYK Q3 Deep Dive: Continued Ortho Momentum, MedSurg Growth, and Focus on M&A",
    "summary": "Medical technology company Stryker (NYSE:SYK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.2% year on year to $6.06 billion. Its non-GAAP profit of $3.19 per share was 1.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=8f863db8969283fc6597cac8d2c5ca660ab118036d88a56ebe3bb8cb55bc0d16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761915348,
      "headline": "SYK Q3 Deep Dive: Continued Ortho Momentum, MedSurg Growth, and Focus on M&A",
      "id": 137279215,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Medical technology company Stryker (NYSE:SYK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.2% year on year to $6.06 billion. Its non-GAAP profit of $3.19 per share was 1.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=8f863db8969283fc6597cac8d2c5ca660ab118036d88a56ebe3bb8cb55bc0d16"
    }
  },
  {
    "ts": null,
    "headline": "Stryker Corp (SYK) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...",
    "summary": "Stryker Corp (SYK) reports robust sales and EPS growth, raises full-year outlook despite facing tariff and supply chain challenges.",
    "url": "https://finnhub.io/api/news?id=b46ff5db1c55a98a0e0efd411512e31f9109793e937c8b5651db1679f2b149c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761879727,
      "headline": "Stryker Corp (SYK) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...",
      "id": 137275141,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker Corp (SYK) reports robust sales and EPS growth, raises full-year outlook despite facing tariff and supply chain challenges.",
      "url": "https://finnhub.io/api/news?id=b46ff5db1c55a98a0e0efd411512e31f9109793e937c8b5651db1679f2b149c1"
    }
  }
]